In the 2019 legislative session, Mississippi introduced bills that sought to increase price transparency, including HB 737, which requires Managed Care plans to include certain fee schedules to providers, establish a physician advisory committee, and establish a billing dispute external review process, and HB 483, which regulates balance billing of facility-based physicians. Additionally, HB 283 would prohibit price gouging of essential drugs. However, none of these initiatives passed at the end of the term.
In the 2018 legislative session, Mississippi introduced several bills to improve price transparency and cost containment for prescription drugs. While most failed to pass, the legislature passed the Prescription Drug Consumer Affordable Alternative Payment Options Act (HB 709), which allows pharmacists to provide patients with information about affordable alternatives of drugs.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.
LEGISLATION: The Database of State Laws Impacting Healthcare Cost and Quality (SLIHCQ), created by The Source on Healthcare Price & Competition and Catalyst for Payment Reform, catalogues state legislation governing price transparency, provider market power, provider payment, provider networks, and benefit design. The database also includes pharmaceutical legislation beginning in the 2017-2018 legislative session. *Note: Current legislative session bill updates are ongoing. Check back weekly for updates.
LITIGATION: The Source tracks major litigation and antitrust enforcement action by federal entities (FTC or DOJ), state attorney generals, and private parties in the main provider and insurer markets, particularly legal challenges of healthcare consolidation and anticompetitive contract provisions. Additionally, the database contains major pharmaceutical cases including legislation challenges and significant appellate cases.
Search the database across all jurisdictions on the State Overview page, or view and filter existing legislation or litigation on individual state pages. The database allows customized search and filter by keyword, status, and/or key issue category. *Multiple filter/selections enabled. Click here for User Guide.
LEGISLATIVE CALENDARMississippi’s latest legislative term ran from 1/8/2019 – 4/8/2019. Mississippi’s next legislative term will begin in 2020.
FY 2019 BUDGETThe State of Mississippi fiscal year runs from July 1 through June 30. Mississippi enacted its FY 2019 Budget in the 2018 regular legislative session. To view Mississippi’s Department of Health FY 2019 spending plan, click here.
REGULATION & ENFORCEMENT
- Mississippi was one of 16 states to file an amicus brief supporting the FTC’s winning position in the Ninth Circuit appeal of St. Luke’s Health Care Sys. v. FTC, No. 14-35173 (March 7, 2014), decided February 10, 2015. The States’ brief stated that the acceleration of health care costs due to the growth of large health care provider systems had become a matter of grave concern for the states.